# Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.

> **NCT00314652** · PHASE3 · COMPLETED · sponsor: **Purdue Pharma LP** · enrollment: 260 (—)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** Buprenorphine transdermal delivery system

## Key facts

- **NCT ID:** NCT00314652
- **Lead sponsor:** Purdue Pharma LP
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-06
- **Primary completion:** —
- **Final completion:** 1999-10
- **Target enrollment:** 260 (—)
- **Last updated:** 2006-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00314652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00314652, "Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00314652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*